Proposed Part D rule changes meet with strong opposition
By Mari Serebrov
Thursday, February 20, 2014
Drugmakers, patient advocacy groups, insurance companies and medical associations are lining up en masse in opposition to proposed changes to Medicare Part D that focus on the bottom line.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.